{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T15:03:08Z","timestamp":1773327788523,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,5,11]],"date-time":"2016-05-11T00:00:00Z","timestamp":1462924800000},"content-version":"vor","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.jdcr.2016.05.007","type":"journal-article","created":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T20:16:22Z","timestamp":1468527382000},"page":"269-271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Systemic methotrexate for prurigo nodularis and keratoacanthomas in actinically damaged skin"],"prefix":"10.1016","volume":"2","author":[{"given":"Amy Kalowitz","family":"Bieber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer A.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jdcr.2016.05.007_bib1","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jaad.2013.03.035","article-title":"Keratoacanthomas arising in association with prurigo nodules in pruritic, actinically damaged skin","volume":"69","author":"Wu","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jdcr.2016.05.007_bib2","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jaad.2006.12.017","article-title":"Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective study and review of the literature","volume":"56","author":"Annest","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jdcr.2016.05.007_bib3","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/120347541201600316","article-title":"Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective case series","volume":"16","author":"Aubut","year":"2012","journal-title":"J Cutan Med Surg"},{"issue":"6","key":"10.1016\/j.jdcr.2016.05.007_bib4","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/0190-9622(91)70301-H","article-title":"Treatment of keratoacanthomas with intralesional methotrexate","volume":"25","author":"Melton","year":"1991","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jdcr.2016.05.007_bib5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1124\/pr.57.2.3","article-title":"Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis","volume":"57","author":"Cronstein","year":"2005","journal-title":"Pharmacol Rev"},{"issue":"3","key":"10.1016\/j.jdcr.2016.05.007_bib6","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0190-9622(98)70508-0","article-title":"Methotrexate in psoriasis: consensus conference","volume":"38","author":"Roenigk","year":"1998","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jdcr.2016.05.007_bib7","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/ced.12365","article-title":"Prurigo nodularis: retrospective study of 13 cases managed with methotrexate","volume":"39","author":"Spring","year":"2014","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"10.1016\/j.jdcr.2016.05.007_bib8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1046\/j.1365-2036.2003.01614.x","article-title":"Bioavailability of oral vs. subcutaneous low-dose methotrexate in patients with Crohn's disease","volume":"18","author":"Kurnik","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.jdcr.2016.05.007_bib9","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/rheumatology\/36.1.86","article-title":"Why intramuscular methotrexate may be more efficacious than oral dosing in patients with rheumatoid arthritis","volume":"36","author":"Hamilton","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.jdcr.2016.05.007_bib10","first-page":"1047","article-title":"Methotrexate bioavailability after oral and subcutaneous administration in children with juvenile idiopathic arthritis","volume":"27","author":"Tukov\u00e1","year":"2009","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10.1016\/j.jdcr.2016.05.007_bib11","first-page":"645","article-title":"Bioavailability of higher dose methotrexate comparing oral and subcutaneous administration in patients with rheumatoid arthritis","volume":"31","author":"Hoekstra","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jdcr.2016.05.007_bib12","series-title":"Otrexup [package insert]","year":"2014"},{"issue":"3","key":"10.1016\/j.jdcr.2016.05.007_bib13","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1006\/clin.1996.0140","article-title":"The mechanism of action of cyclosporin A and FK506","volume":"80","author":"Ho","year":"1996","journal-title":"Clin Immunol Immunopathol"},{"issue":"17","key":"10.1016\/j.jdcr.2016.05.007_bib14","doi-asserted-by":"crossref","first-page":"11968","DOI":"10.1016\/S0021-9258(19)49791-3","article-title":"Leukocyte chemotactic activity of cyclophilin","volume":"267","author":"Xu","year":"1992","journal-title":"J Biol Chem"},{"issue":"6719","key":"10.1016\/j.jdcr.2016.05.007_bib15","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/17401","article-title":"Cyclosporine induces cancer progression by a cell-autonomous mechanism","volume":"397","author":"Hojo","year":"1999","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.jdcr.2016.05.007_bib16","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/01.mlg.0000205170.24517.28","article-title":"Molecular basis of posttransplant squamous cell carcinoma: the potential role of cyclosporine a in carcinogenesis","volume":"116","author":"Tiu","year":"2006","journal-title":"Laryngoscope"},{"issue":"3","key":"10.1016\/j.jdcr.2016.05.007_bib17","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/rheumatology\/kem279","article-title":"Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis","volume":"47","author":"Wessels","year":"2008","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.jdcr.2016.05.007_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1440-0960.2011.00839.x","article-title":"The use of methotrexate in dermatology: a review","volume":"53","author":"Shen","year":"2012","journal-title":"Australas J Dermatol"},{"issue":"11","key":"10.1016\/j.jdcr.2016.05.007_bib19","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1002\/1097-0142(19940601)73:11<2759::AID-CNCR2820731118>3.0.CO;2-C","article-title":"The carcinogenic risk of treatments for severe psoriasis","volume":"73","author":"Stern","year":"1994","journal-title":"Cancer"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512616300352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512616300352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:17:08Z","timestamp":1762474628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512616300352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S2352512616300352"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2016.05.007","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic methotrexate for prurigo nodularis and keratoacanthomas in actinically damaged skin","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2016.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}